Purchases and Sales Made in Q2 2024 in Bei Gene, Ltd. (BGNE)
This table provides information about the institutional ownership of Bei Gene, Ltd. (BGNE) during Q2 2024. The information is specifically focused on institutions that hold shares of BeiGene, Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2024
Q2 2024
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-50.9K- 0.72% |
$6.59M - $8.87M
|
7.01M
$1.59B
|
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-52.4K- 50.21% |
$6.79M - $9.14M
|
52K
$11.8M
|
|
|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-55.5K- 33.77% |
$7.19M - $9.67M
|
109K
$24.7M
|
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-65.8K- 18.62% |
$8.52M - $11.5M
|
287K
$65.1M
|
|
|
Aug 13, 2024
Q2 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-94.8K- 46.01% |
$12.3M - $16.5M
|
111K
$25.2M
|
|
|
Aug 14, 2024
Q2 2024
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-101K- 25.05% |
$13.1M - $17.7M
|
303K
$68.8M
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-652K- 88.37% |
$84.5M - $114M
|
85.8K
$19.5M
|